Sharing this excellent body of work for the biologics geeks out there.
Calcium Orthophosphate (CaPO4) Containing Composites for Biomedical Applications: Formulations, Properties,
and Applications
Link to publication – https://www.mdpi.com/2504-477X/8/6/218
| Producer | Product Name | Composition | Form |
|---|---|---|---|
| Allergan Aesthetics | HArmonyCa™ | HA, hyaluronic acid, 0.3% lidocaine | pre-mixed |
| ApaTech (UK) | Actifuse™ | HA, polymer and aqueous solution | pre-mixed |
| Actifuse™ Shape | Si-substituted CaPO4 and a polymer | pre-mixed||
| Baxter (US) | TricOs Τ | BCP (60% HA, 40% β-TCP) granules and Tissucol (fibrin glue) | to be mixed |
| Berkeley Advanced Biomaterials | Bi-Ostetic Putty | not disclosed | not disclosed |
| BioForm (US) | Calcium hydroxylapatite implant | HA powder embedded in a mixture of glycerine, water and CMC | pre-mixed |
| Biomatlante (FR) | In’Oss™ | BCP granules (60% HA, 40% β-TCP; 0.08–0.2 mm) and 2% HPMC | pre-mixed |
| MBCP Gel® | BCP granules (60% HA, 40% β-TCP; 0.08–0.2 mm) and 2% HPMC | pre-mixed | |
| Hydr’Os | BCP granules (60% HA, 40% β-TCP; micro- and nanosized particles) and saline solution | pre-mixed | |
| Bioceramed (PT) | k-IBS® | BCP granules (75% HA, 25% β-TCP; 0.125–0.355 mm) and chitosan dissolved in PEG | pre-mixed |
| n-IBS® | Aqueous suspension of HA powders | pre-mixed | |
| Degradable Solutions (CH) | Easy graft™ | β-TCP or BCP granules (0.45–1.0 mm) coated with 10 μm PLGA, N-methyl-2-pyrrolydone | to be mixed |
| Dentsply (US) | Pepgen P-15® flow | HA (0.25–0.42 mm), P-15 peptide and aqueous Na hyaluronate solution | to be mixed |
| DePuy Spine (US) | Healos® Fx | HA (20–30%) and collagen | to be mixed |
| Fluidinova (P) | nanoXIM TCP | β-TCP (5 or 15%) and water | pre-mixed |
| nanoXIM HA | HA (5, 15, 30 or 40%) and water | pre-mixed | |
| Integra LifeSciences (US) | Mozaik Osteoconductive Scaffold | β-TCP (80%) and type 1 collagen (20%) | to be mixed |
| Ceros® Putty/cyclOS® | β-TCP granules (0.125–0.71 mm; 94%) and recombinant Na hyaluronate powder (6%) | to be mixed | |
| Mathys Ltd. (CH) | Putty | to be mixed | |
| Medtronic (US) | Mastergraft® | BCP (85% HA, 15% β-TCP) and bovine collagen | to be mixed |
| Merz Aesthetics (GER) | RADIESSE® | HA particles suspended in a gel | pre-mixed |
| NuVasive (USA) | AttraX® putty | β-TCP and alkylene oxide copolymer | pre-mixed |
| Osartis/ΑΑΡ (GER) | Ostim® | Nanocrystalline HA (35%) and water (65%) | pre-mixed |
| Smith & Nephew (US) | JAXTCP | β-TCP granules and an aqueous solution of 1.75% CMC and 10% glycerol | to be mixed |
| Stryker (US) | Calstrux™ | β-TCP granules and CMC | to be mixed |
| Teknimed (FR) | Nanogel | HA (100–200 nm) (30%) and water (70%) | pre-mixed |
| Therics (US) | Therigraft™ Putty | β-TCP granules and polymer | pre-mixed |
| Zimmer (US) | Collagraft | BCP granules (65% HA, 35% β-TCP; 0.5–1.0 mm) | to be mixed |